Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fluocinolone acetonide + acetic acid** is a topical otic (ear) combination drug consisting of **fluocinolone acetonide**, a synthetic fluorinated corticosteroid, and **acetic acid**, an antibacterial and acidifying agent. Fluocinolone acetonide acts as a potent anti-inflammatory and antipruritic agent by inducing phospholipase A2 inhibitory proteins (lipocortins), which reduce the release of arachidonic acid, thereby decreasing synthesis of pro-inflammatory mediators (prostaglandins, leukotrienes). Acetic acid creates an acidic environment in the ear canal, inhibiting bacterial and fungal growth. The combination is primarily used in the management of chronic eczematous external otitis (eczema and inflammation of the outer ear canal), with acetic acid providing antibacterial activity and fluocinolone acetonide reducing inflammation, swelling, and itching.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluocinolone acetonide + acetic acid.